The stock of Davita Inc (NYSE:DVA) is a huge mover today! The stock decreased 2.98% or $1.97 during the last trading session, hitting $64.1. About 2.88 million shares traded hands or 41.18% up from the average. Davita Inc (NYSE:DVA) has declined 6.03% since March 1, 2016 and is downtrending. It has underperformed by 18.24% the S&P500.
The move comes after 7 months negative chart setup for the $13.39B company. It was reported on Oct, 4 by Barchart.com. We have $58.97 PT which if reached, will make NYSE:DVA worth $1.07 billion less.
Analysts await Davita Inc (NYSE:DVA) to report earnings on November, 1. They expect $0.93 EPS, down 7.00% or $0.07 from last year’s $1 per share. DVA’s profit will be $194.27M for 17.23 P/E if the $0.93 EPS becomes a reality. After $1.01 actual EPS reported by Davita Inc for the previous quarter, Wall Street now forecasts -7.92% negative EPS growth.
Davita Inc (NYSE:DVA) Ratings Coverage
Out of 6 analysts covering DaVita (NYSE:DVA), 1 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 17% are positive. DaVita has been the topic of 11 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The company was upgraded on Tuesday, September 20 by Raymond James. The firm has “Sector Perform” rating by RBC Capital Markets given on Tuesday, February 16. The firm earned “Neutral” rating on Tuesday, August 9 by JP Morgan. RBC Capital Markets maintained Davita Inc (NYSE:DVA) on Wednesday, November 4 with “Sector Perform” rating. The firm earned “Neutral” rating on Tuesday, September 6 by Citigroup. The firm has “Market Perform” rating given on Wednesday, March 2 by Bernstein. The stock of Davita Inc (NYSE:DVA) earned “Neutral” rating by JP Morgan on Wednesday, September 16. On Tuesday, September 6 the stock rating was downgraded by Bank of America to “Neutral”. The rating was maintained by RBC Capital Markets with “Sector Perform” on Thursday, August 6.
According to Zacks Investment Research, “DaVita HealthCare Partners Inc. provides dialysis services to patients with chronic kidney failure and end stage renal disease primarily in the United States. The company offers outpatient, home-based, and hospital inpatient hemodialysis services, ESRD laboratory services and provides management and administrative services to outpatient dialysis centers. DaVita HealthCare Partners Inc., formerly known as DaVita Inc., is headquartered in Denver, Colorado.”
Insitutional Activity: The institutional sentiment increased to 1.04 in 2016 Q2. Its up 0.03, from 1.01 in 2016Q1. The ratio is positive, as 34 funds sold all Davita Inc shares owned while 162 reduced positions. 51 funds bought stakes while 153 increased positions. They now own 171.18 million shares or 3.23% less from 176.89 million shares in 2016Q1.
Skba Capital Limited Liability Corp accumulated 0.05% or 6,635 shares. Capstone Asset accumulated 0.05% or 22,043 shares. Timessquare Capital Mgmt holds 4.15 million shares or 2.12% of its portfolio. Oppenheimer Incorporated owns 26,751 shares or 0.06% of their US portfolio. The Illinois-based Calamos Advsrs Limited Liability has invested 0.01% in Davita Inc (NYSE:DVA). Moreover, Cibc World has 0.01% invested in Davita Inc (NYSE:DVA) for 19,717 shares. Guardian Life Insur Of America last reported 0% of its portfolio in the stock. Moreover, Mark Sheptoff Fincl Planning Llc has 2.15% invested in Davita Inc (NYSE:DVA) for 37,137 shares. Tcw Grp Inc Inc accumulated 0.01% or 11,950 shares. The Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.02% in Davita Inc (NYSE:DVA). Deutsche Bank & Trust Ag last reported 529,180 shares in the company. Fayez Sarofim And accumulated 8,100 shares or 0% of the stock. Advantus Capital owns 16,018 shares or 0.03% of their US portfolio. Hutchin Hill Capital Limited Partnership holds 0.04% of its portfolio in Davita Inc (NYSE:DVA) for 15,000 shares. Cacti Asset Ltd last reported 4,050 shares in the company.
Insider Transactions: Since April 11, 2016, the stock had 0 insider buys, and 13 insider sales for $19.13 million net activity. ZUMWALT LEANNE M sold $41,469 worth of Davita Inc (NYSE:DVA) on Tuesday, May 17. Rodriguez Javier had sold 89,912 shares worth $6.61M. Shares for $1.48 million were sold by STAFFIERI MICHAEL DAVID on Tuesday, August 9. Kogod Dennis sold $3.05M worth of stock or 40,048 shares. Another trade for 10,824 shares valued at $835,216 was made by Arway Pamela M on Wednesday, May 25. HILGER JAMES K sold $301,073 worth of Davita Inc (NYSE:DVA) on Friday, May 13. Shares for $1.23 million were sold by NEHRA JOHN M.
More recent Davita Inc (NYSE:DVA) news were published by: Prnewswire.com which released: “Over 500 Cyclists Ride in 10th Annual Tour DaVita to Raise Funds and Awareness …” on September 23, 2016. Also Prnewswire.com published the news titled: “DaVita Kidney Care Celebrates First Day of Autumn with Slow Cooker Cookbook” on September 22, 2016. Prnewswire.com‘s news article titled: “DaVita Names New President for Florida Medical Group Operations” with publication date: September 14, 2016 was also an interesting one.
DVA Company Profile
DaVita Inc., formerly DaVita HealthCare Partners Inc., incorporated on April 4, 1994, is a well-known provider of kidney care services. The Firm operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s divisions include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a well-known provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.